Chemotherapy for patients with circulating tumour DNA positive, stage II colon cancer (CIRCULATE) - an AIO / ABCSG trial
{{output}}
Background: Adjuvant chemotherapy provides limited benefit in unselected stage II colon cancer. Postoperative ctDNA has higher prognostic value than classical clinical markers, with ctDNA positivity indicating an unfavourable out... ...
